Blood boosting

British Journal of Sports Medicine

Volumn 38, Issue 1, 2004, Pages 99-101

  Leigh Smith, S ^a  

^a Defence Medical Services   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT ERYTHROPOIETIN;

ASSOCIATION; ATHLETE; BIOSAFETY; BLOOD ANALYSIS; ERYTHROPOIESIS; HISTORY OF MEDICINE; HUMAN; REVIEW; TECHNIQUE;

BLOOD TRANSFUSION; CRYOPRESERVATION; DOPING IN SPORTS; ERYTHROCYTE TRANSFUSION; HUMANS; SPORTS; SUBSTANCE ABUSE DETECTION;

EID: 0842309068     PISSN: 03063674     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjsm.2003.007195     Document Type: Review

References (39)

1. Eichner E. Better dead than second. J Lab Clin Med 1992;120:359-60.
2. d'Onofrio G, Zini G. Addendum to strategies to deter blood doping in sports. Haematologica 2002;87(07):ELT31.
3. Kamber M. Fight against doping-national and international developments after Tour de France 1998. Ther Umsch 2001;58:220-5.
4. Ashenden M. A strategy to deter blood doping in sport. Haematologica 2002;87:225-34.
5. Craig AJ. Olympics 1968: a post mortem. Med Sci Sports 1969;1:177.
6. Burke E. Performance enhancement: blood boosting, erythropoietin, and steroids. Philadelphia: Hanley & Belfus, 1994.
7. Berglund B. Development of techniques for the detection of blood doping in sport. Sports Med 1988;5:127-35.
8. Cazzola M. A global strategy for prevention and detection of blood doping with erythropoietin and related drugs. Haematologica 2000;85:561-3.
9. Voy R, Deter K. Drugs, sport and politics. Champaign, IL: Leisure Press, 1991.
10. Jones M, Tunstall Pedoe D. Blood doping: a literature review. Br J Sports Med 1989;23:84-8.
11. Berglund B, Hemmingsson P, Birgegard G. Detection of autologous blood transfusions in cross country skiers. Int J Sports Med 1987;8:66-70.
12. Smith D, Perry P. The efficacy of ergogenic agents in athletic competition. Part II. Other performance-enhancing agents. Ann Pharmacother 1992;26:653-9.
13. Berglund B, Birgegard G, Wide L, et al. Effects of blood transfusions on some haematological variables in endurance athletes. Med Sci Sports Exerc 1989;21:637-42.
14. McArdle W. Exercise physiology: energy, nutrition, and human performance, 4th ed. Baltimore: Lippincott Williams & Wilkins, 1986.
15. Wilmore J, Costill D. The physiological basis of the conditioning process. Training for sport and activity, 3rd ed. Dubuque, IA: Human Kinetics, 1988:255-257.
16. Cowart V. Erythropoietin: a dangerous new form of drug doping. Physician and Sports Medicine 1989;17:115-18.
17. Hickson R, Foster C, Pollock M, et al. Reduced training intensities and loss of aerobic power, endurance, and cardiac growth. J Appl Physiol 1985;58:492-9.
18. Gledhill N. Blood doping and related issues: a brief review. Med Sci Sports Exerc 1982;14:183-9.
19. Ghaphery N. Performance-enhancing drugs. Orthop Clin North Am 1995;26:433-42.
20. 2max, blood doping, and erythropoietin. Br J Sports Med 2003;37:190-1.
21. Pace N, El L, Consolazio W, et al. The increase in hypoxic tolerance of normal men accompanying the polycythaemia induced by transfusion of erythrocytes. Am J Physiol 1947;148:152-63.
22. Ekblom B, Goldbarg A, Gullbring B. Response to exercise after blood loss and reinfusion. J Appl Physiol 1972;33:175-80.
23. Ekblom B. Blood boosting and sport. Best Pract Res Clin Endocrinol Metab 2000;14:89-98.
24. Buick F, Gkedhill N, Froese A, et al. Effect of induced erythrocythemia on aerobic work capacity. J Appl Physiol 1980;48:636-42.
25. Spriet L, Gledhill N, Froese A, et al. Effect of graded erythrocythemia on cardiovascular and metabolic responses to exercise. J Appl Physiol 1986;61:1942-8.
26. Robertson RJ, Gilcher R, Metz K, et al. Effect of induced erythrocythemia on hypoxia tolerance during exercise. J Appl Physiol 1982;53:490-5.
27. Brien A, Simon T, et al. The effects of red blood cell infusion on 10-km race time. JAMA 1987;257:2761-5.
28. Williams M, Wesseldine S, Somma T. The effect of induced erythrocythemia upon 5-mile treadmill run time. Med Sci Sports Exerc 1981;13:169-75.
29. Ekblom B, Berglund B. Effect of erythropoietin administraion on maximal aerobic power. Scond J Med Sci Sports 1991;1:88-93.
30. Sawka M, Young A. Acute polycythemia and human performance during exercise and exposure to extreme environments. Exerc Sport Sci Rev 1989;17:265-93.
31. Gledhill N, Warburton D, Jamnik V. Haemoglobin, blood volume, cardiac function, and aerobic power. Can J Appl Physiol 1999;24:54-65.
32. Dowling P. Erythropoietin a review. Sports Health 1990;8:30-2.
33. Sawka M, Dennis R, Gonzalez R. Influence of polycythemia on blood volume and thermoregulation during exercise-heat stress. J Appl Physiol 1987;62:912-18.
34. Sawka M, Gonzalez R, Young A. Polycythemia and hydration: effects on thermoregulation and blood volume during exercise-heat stress. Am J Physiol 1988;255:456-63.
35. Klein H. Blood transfusion and athletics: gmes people play. N Engl J Med 1985;312:854-6.
36. Goodnough L, Monk T, Andriole G. Erythropoietin therapy. N Engl J Med 1997;336:933-8.
37. Brugnara C, Chambers L, Malynn E, et al. Red blood cell regeneration induced by subcutaneous recombinant erythropoietin: iron-deficient erythropoiesis in iron-replete subjects. Blood 1993;81:956-64.
38. Mercuriali Fea, Zanella A, Barosi G. Use of erythropoietin to increase the volume of autologous blood donated by orthopedic patients. Transfusion 1993;33:55-60.
39. Fagerholl M, Heier H. Detection of transfused allogenic blood. In: Hemmersbach P, Birkland K, eds. Blood samples doping control. Oslo: On demand, 1991:161-2.